Showing 5881-5890 of 20432 results for "".
- New Frontiers in Treating Eosinophilic COPD: Mepolizumab and Ensifentrinehttps://reachmd.com/news/new-frontiers-in-treating-eosinophilic-copd-mepolizumab-and-ensifentrine/2474987/Managing recurrent exacerbations in patients with eosinophilic COPD remains a clinical challenge, as traditional therapies may not always effectively break the cycle of airway inflammation, particularly in patients with higher eosinophil leve
- New Collaboration Enhances Precision and Patient Engagement in Post-Weight-Loss Treatmentshttps://reachmd.com/news/new-collaboration-enhances-precision-and-patient-engagement-in-post-weight-loss-treatments/2475376/MNML Aesthetics announced a partnership with ShapeScale to integrate 3D body imaging into its MNML Tone Method, a multi-modality body contouring protocol. The collaboration aims to enhance clinical precision and patient engagement in aesthetic practices, particularly in post-weight-loss body tran
- Revolutionizing our Understanding of Brain Plasticity: The Role of Distinct Transmission Siteshttps://reachmd.com/news/revolutionizing-our-understanding-of-brain-plasticity-the-role-of-distinct-transmission-sites/2475014/Recent research indicates that brain plasticity involves specific transmission sites, which challenges established theories and offers new insights for cognitive science. For decades, the neuroscience community operate
- Evolving Strategies in Skin Cancer: Mohs Surgery for High-Stage cSCChttps://reachmd.com/news/evolving-strategies-in-skin-cancer-mohs-surgery-for-high-stage-cscc/2475012/As high-stage cutaneous squamous cell carcinoma cases continue to challenge dermatologists, Mohs surgery is contributing to improved outcomes by providing enhanced precision in tumor removal and reducing recurrence rates. High-stage cu
- Nasal Spray Gene Therapy: A Breakthrough in Targeted Pulmonary Treatmenthttps://reachmd.com/news/nasal-spray-gene-therapy-a-breakthrough-in-targeted-pulmonary-treatment/2474967/Advancements in pulmonary medicine are focusing on delivering gene therapy precisely to bronchiolar and alveolar tissues; new methods using nasal spray are being investigated for their potential to improve targeting efficiency in respiratory
- Addressing Copathologies in Alzheimer's Diseasehttps://reachmd.com/news/addressing-copathologies-in-alzheimers-disease/2474969/Understanding the nuanced landscape of Alzheimer’s requires recognizing and addressing copathologies that significantly influence symptom severity and disease progression, as underscored by
- Pediatric Vaccination Strategies: Navigating SARS-CoV-2 Variant Challenges for 2025–26https://reachmd.com/news/pediatric-vaccination-strategies-navigating-sars-cov-2-variant-challenges-for-202526/2474968/As SARS-CoV-2 continues to evolve, pediatric vaccination strategies face underrecognized challenges that will shape the 2025–26 immunization landscape. The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) conv
- Evolving Role of Therapeutic Hypothermia in TBI: Modulating Tau Protein Dynamics for Enhanced Neuroprotectionhttps://reachmd.com/news/evolving-role-of-therapeutic-hypothermia-in-tbi-modulating-tau-protein-dynamics-for-enhanced-neuroprotection/2474981/Therapeutic hypothermia is emerging as a pivotal intervention in TBI treatment by directly targeting tau protein dynamics to limit neuronal damage and enhance neuro-recovery. Neurologists and neurointensivists continue to confront the
- Optimizing Botulinum Toxin Formulations for Fast and Lasting Cosmetic Resultshttps://reachmd.com/news/optimizing-botulinum-toxin-formulations-for-fast-and-lasting-cosmetic-results/2474980/Demand for rapid and enduring cosmetic improvements is driving dermatologists to refine their selection of botulinum toxin formulations in glabellar line treatments. Given patient expectations for visible results, practitioners in Cosm
- Pivekimab Sunirine: A New Hope for BPDCN Treatmenthttps://reachmd.com/news/pivekimab-sunirine-a-new-hope-for-bpdcn-treatment/2474977/BPDCN remains an aggressive rare blood cancer with limited treatment options, and the introduction of Pivekimab Sunirine may influence outcomes for this challenging condition. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is mar